Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Phreesia, Inc. (PHR)
since 2019 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Phreesia, Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1412408.
Total stock buying since 2019: $0.
Total stock sales since 2019: $395,710,356.
Total stock option exercises since 2019: $5,597,798.
Table 3. Detailed insider trading at Phreesia, Inc. (PHR) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2024-04-15 | Indig Chaim (Chief Executive Officer) | Sale | 3,392 | 22.86 | 77,530 |
| 2024-04-15 | Linetsky David (SVP, Life Sciences) | Sale | 2,212 | 22.86 | 50,559 |
| 2024-04-15 | Roberts Evan (Chief Operating Officer) | Sale | 2,029 | 22.86 | 46,376 |
| 2024-04-15 | Hoffman Allison C (General Counsel & Secretary) | Sale | 1,238 | 22.86 | 28,296 |
| 2024-04-10 | Gunzburg Janet (Principal Accounting Officer) | Sale | 2,768 | 23.09 | 63,926 |
| 2024-04-09 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 3,768 | 23.43 | 88,276 |
| 2024-04-09 | Roberts Evan (Chief Operating Officer) | Option Ex | 23,330 | 2.03 | 47,359 |
| 2024-04-09 | Hoffman Allison C (General Counsel & Secretary) | Sale | 4,626 | 23.42 | 108,359 |
| 2024-04-08 | Gandhi Balaji (Chief Financial Officer) | Sale | 7,778 | 22.82 | 177,462 |
| 2024-04-08 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 3,354 | 22.82 | 76,524 |
| 2024-04-08 | Indig Chaim (Chief Executive Officer) | Sale | 12,043 | 22.82 | 274,773 |
| 2024-04-08 | Linetsky David (SVP, Life Sciences) | Sale | 4,161 | 22.82 | 94,937 |
| 2024-04-08 | Roberts Evan (Chief Operating Officer) | Sale | 7,178 | 22.82 | 163,773 |
| 2024-04-08 | Gunzburg Janet (Principal Accounting Officer) | Sale | 1,709 | 22.82 | 38,992 |
| 2024-04-08 | Hoffman Allison C (General Counsel & Secretary) | Sale | 5,549 | 22.82 | 126,605 |
| 2024-03-25 | Gandhi Balaji (Chief Financial Officer) | Sale | 3,504 | 23.21 | 81,331 |
| 2024-03-21 | Roberts Evan (Chief Operating Officer) | Sale | 25,962 | 23.97 | 622,335 |
| 2024-03-20 | Linetsky David (SVP, Life Sciences) | Sale | 30 | 23.66 | 709 |
| 2024-03-20 | Gunzburg Janet (Principal Accounting Officer) | Sale | 137 | 23.66 | 3,241 |
| 2024-03-19 | Linetsky David (SVP, Life Sciences) | Sale | 402 | 23.27 | 9,355 |
| 2024-03-19 | Gunzburg Janet (Principal Accounting Officer) | Sale | 2,817 | 23.27 | 65,560 |
| 2024-03-18 | Linetsky David (SVP, Life Sciences) | Sale | 46 | 22.22 | 1,021 |
| 2024-02-09 | Gunzburg Janet (Principal Accounting Officer) | Sale | 480 | 28.00 | 13,440 |
| 2024-02-02 | Gunzburg Janet (Principal Accounting Officer) | Sale | 480 | 27.00 | 12,960 |
| 2024-02-01 | Gunzburg Janet (Principal Accounting Officer) | Sale | 328 | 25.99 | 8,524 |
| 2024-01-17 | Gandhi Balaji (Chief Financial Officer) | Sale | 9,192 | 24.12 | 221,729 |
| 2024-01-17 | Davidoff Michael J. (SVP, Payer Business) | Sale | 17,677 | 24.12 | 426,404 |
| 2024-01-17 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 10,213 | 24.12 | 246,357 |
| 2024-01-17 | Indig Chaim (Chief Executive Officer) | Sale | 63,931 | 24.12 | 1,542,143 |
| 2024-01-17 | Linetsky David (SVP, Life Sciences) | Sale | 30,659 | 24.12 | 739,556 |
| 2024-01-17 | Roberts Evan (Chief Operating Officer) | Sale | 41,081 | 24.12 | 990,955 |
| 2024-01-17 | Hoffman Allison C (General Counsel & Secretary) | Sale | 7,605 | 24.12 | 183,447 |
| 2024-01-16 | Gandhi Balaji (Chief Financial Officer) | Sale | 932 | 24.55 | 22,876 |
| 2024-01-16 | Davidoff Michael J. (SVP, Payer Business) | Sale | 1,310 | 24.55 | 32,155 |
| 2024-01-16 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 738 | 24.55 | 18,114 |
| 2024-01-16 | Indig Chaim (Chief Executive Officer) | Sale | 3,586 | 24.55 | 88,021 |
| 2024-01-16 | Linetsky David (SVP, Life Sciences) | Sale | 2,318 | 24.55 | 56,897 |
| 2024-01-16 | Roberts Evan (Chief Operating Officer) | Sale | 2,247 | 24.55 | 55,154 |
| 2024-01-16 | Hoffman Allison C (General Counsel & Secretary) | Sale | 1,316 | 24.55 | 32,302 |
| 2024-01-12 | Gunzburg Janet (Principal Accounting Officer) | Sale | 205 | 24.11 | 4,942 |
| 2023-12-19 | Linetsky David (SVP, Life Sciences) | Sale | 25 | 23.72 | 593 |
| 2023-12-19 | Gunzburg Janet (Principal Accounting Officer) | Sale | 118 | 23.72 | 2,799 |
| 2023-12-18 | Linetsky David (SVP, Life Sciences) | Sale | 334 | 23.15 | 7,732 |
| 2023-11-01 | Gunzburg Janet (Principal Accounting Officer) | Sale | 298 | 13.38 | 3,988 |
| 2023-10-31 | Roberts Evan (Chief Operating Officer) | Option Ex | 30,000 | 2.03 | 60,899 |
| 2023-10-16 | Gandhi Balaji (Chief Financial Officer) | Sale | 861 | 16.61 | 14,300 |
| 2023-10-16 | Davidoff Michael J. (SVP, Payer Business) | Sale | 1,198 | 16.61 | 19,897 |
| 2023-10-16 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 665 | 16.61 | 11,044 |
| 2023-10-16 | Indig Chaim (Chief Executive Officer) | Sale | 3,295 | 16.61 | 54,726 |
| 2023-10-16 | Linetsky David (SVP, Life Sciences) | Sale | 2,078 | 16.61 | 34,513 |
| 2023-10-16 | Roberts Evan (Chief Operating Officer) | Sale | 1,971 | 16.61 | 32,736 |
| 2023-10-16 | Hoffman Allison C (General Counsel & Secretary) | Sale | 1,297 | 16.61 | 21,541 |
| 2023-09-18 | Linetsky David (SVP, Life Sciences) | Sale | 130 | 19.70 | 2,560 |
| 2023-09-18 | Gunzburg Janet (Principal Accounting Officer) | Sale | 125 | 19.79 | 2,473 |
| 2023-09-14 | Davidoff Michael J. (SVP, Payer Business) | Sale | 2,953 | 20.16 | 59,538 |
| 2023-09-14 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 2,000 | 20.16 | 40,316 |
| 2023-09-14 | Hoffman Allison C (General Counsel & Secretary) | Sale | 2,210 | 20.17 | 44,566 |
| 2023-09-13 | Gandhi Balaji (Chief Financial Officer) | Sale | 3,957 | 20.75 | 82,123 |
| 2023-09-13 | Davidoff Michael J. (SVP, Payer Business) | Sale | 3,606 | 20.75 | 74,838 |
| 2023-09-13 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 1,826 | 20.75 | 37,896 |
| 2023-09-13 | Indig Chaim (Chief Executive Officer) | Sale | 6,555 | 20.75 | 136,042 |
| 2023-09-13 | Linetsky David (SVP, Life Sciences) | Sale | 2,178 | 20.75 | 45,202 |
| 2023-09-13 | Roberts Evan (Chief Operating Officer) | Sale | 3,907 | 20.75 | 81,085 |
| 2023-09-13 | Gunzburg Janet (Principal Accounting Officer) | Sale | 934 | 20.75 | 19,384 |
| 2023-09-13 | Hoffman Allison C (General Counsel & Secretary) | Sale | 3,256 | 20.75 | 67,575 |
| 2023-09-12 | Linetsky David (SVP, Life Sciences) | Option Ex | 11,853 | 5.82 | 68,948 |
| 2023-09-08 | Roberts Evan (Chief Operating Officer) | Option Ex | 30,000 | 2.03 | 60,899 |
| 2023-07-21 | Davidoff Michael J. (SVP, Payer Business) | Sale | 1,075 | 31.75 | 34,131 |
| 2023-05-10 | Munson Gillian | Sale | 3,555 | 30.06 | 106,863 |
| 2023-05-09 | Indig Chaim (Chief Executive Officer) | Option Ex | 12,453 | 8.03 | 99,997 |
| 2023-04-21 | Davidoff Michael J. (SVP, Payer Business) | Sale | 1,075 | 33.13 | 35,614 |
| 2023-04-18 | Roberts Evan (Chief Operating Officer) | Sale | 7,452 | 32.09 | 239,164 |
| 2023-04-17 | Gandhi Balaji (Chief Financial Officer) | Sale | 2,113 | 31.83 | 67,248 |
| 2023-04-17 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 570 | 31.84 | 18,148 |
| 2023-04-17 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 21,387 | .84 | 17,965 |
| 2023-04-17 | Roberts Evan (Chief Operating Officer) | Sale | 2,600 | 32.01 | 83,228 |
| 2023-04-14 | Hoffman Allison C (General Counsel & Secretary) | Sale | 3,306 | 31.16 | 103,018 |
| 2023-04-12 | Roberts Evan (Chief Operating Officer) | Sale | 200 | 32.01 | 6,402 |
| 2023-04-11 | Davidoff Michael J. (SVP, Payer Business) | Sale | 3,466 | 30.91 | 107,123 |
| 2023-04-03 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 2,978 | 31.19 | 92,889 |
| 2023-04-03 | Smith Mark Douglas | Sale | 7,000 | 31.23 | 218,610 |
| 2023-04-03 | Smith Mark Douglas | Option Ex | 7,000 | 4.71 | 32,970 |
| 2023-02-02 | Rasmussen Randy (Chief Financial Officer) | Sale | 4,765 | 40.00 | 190,600 |
| 2023-02-02 | Davidoff Michael J. (SVP, Payer Business) | Sale | 7,513 | 39.34 | 295,531 |
| 2023-02-02 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 300 | 40.00 | 12,000 |
| 2023-02-02 | Linetsky David (SVP, Life Sciences) | Sale | 11,378 | 39.55 | 449,988 |
| 2023-01-31 | Davidoff Michael J. (SVP, Payer Business) | Sale | 3,265 | 38.00 | 124,083 |
| 2023-01-30 | Davidoff Michael J. (SVP, Payer Business) | Sale | 28,555 | 36.07 | 1,030,035 |
| 2023-01-30 | Davidoff Michael J. (SVP, Payer Business) | Option Ex | 12,090 | 6.37 | 77,013 |
| 2023-01-18 | Hoffman Allison C (General Counsel & Secretary) | Sale | 649 | 36.07 | 23,406 |
| 2022-12-15 | Linetsky David (SVP, Life Sciences) | Sale | 22 | 34.01 | 748 |
| 2022-12-12 | Rasmussen Randy (Chief Financial Officer) | Sale | 7,395 | 31.77 | 234,916 |
| 2022-12-09 | Rasmussen Randy (Chief Financial Officer) | Sale | 9,934 | 30.78 | 305,808 |
| 2022-12-09 | Linetsky David (SVP, Life Sciences) | Sale | 26,837 | 29.77 | 799,071 |
| 2022-11-02 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 19,341 | 27.18 | 525,707 |
| 2022-10-18 | Davidoff Michael J. (SVP, Payer Business) | Sale | 2,150 | 25.26 | 54,308 |
| 2022-09-16 | Davidoff Michael J. (SVP, Payer Business) | Sale | 6,480 | 27.60 | 178,860 |
| 2022-09-15 | Hoffman Allison C (General Counsel & Secretary) | Sale | 6,450 | 28.58 | 184,325 |
| 2022-07-21 | Davidoff Michael J. (SVP, Payer Business) | Sale | 1,404 | 25.00 | 35,100 |
| 2022-07-11 | Munson Gillian | Sale | 2,605 | 25.57 | 66,599 |
| 2022-07-07 | Vanduyn Amy Beth (SVP, Human Resources) | Option Ex | 20,000 | .84 | 16,800 |
| 2022-06-24 | Davidoff Michael J. (SVP, Payer Business) | Sale | 5,046 | 25.11 | 126,705 |
| 2022-05-16 | Munson Gillian | Sale | 2,106 | 16.06 | 33,816 |
| 2022-05-09 | Hoffman Allison C (General Counsel & Secretary) | Sale | 3,909 | 17.50 | 68,399 |
| 2022-02-18 | Indig Chaim (Chief Executive Officer) | Option Ex | 78,106 | 6.37 | 497,535 |
| 2022-01-21 | Roberts Evan (Chief Operating Officer) | Option Ex | 25,000 | 2.03 | 50,749 |
| 2022-01-19 | Rasmussen Randy (Chief Financial Officer) | Sale | 2,228 | 32.62 | 72,666 |
| 2022-01-11 | Roberts Evan (Chief Operating Officer) | Option Ex | 43,750 | .84 | 36,750 |
| 2022-01-07 | Indig Chaim (Chief Executive Officer) | Option Ex | 84,270 | 2.03 | 171,068 |
| 2022-01-06 | Linetsky David (SVP, Life Sciences) | Option Ex | 30,950 | 5.82 | 180,036 |
| 2021-12-31 | Davidoff Michael J. (See remarks) | Option Ex | 12,798 | 4.71 | 60,278 |
| 2021-12-09 | Indig Chaim (Chief Executive Officer) | Option Ex | 50,000 | 2.03 | 101,499 |
| 2021-12-09 | Roberts Evan (Chief Operating Officer) | Option Ex | 50,000 | .84 | 42,000 |
| 2021-11-09 | Rasmussen Randy (Chief Financial Officer) | Sale | 7,185 | 73.98 | 531,539 |
| 2021-11-08 | Linetsky David (SVP, Life Sciences) | Sale | 1,499 | 75.12 | 112,606 |
| 2021-11-08 | Linetsky David (SVP, Life Sciences) | Option Ex | 1,499 | 4.71 | 7,060 |
| 2021-11-05 | Linetsky David (SVP, Life Sciences) | Sale | 3,478 | 75.15 | 261,382 |
| 2021-11-05 | Linetsky David (SVP, Life Sciences) | Option Ex | 3,478 | 4.71 | 16,381 |
| 2021-11-01 | Linetsky David (SVP, Life Sciences) | Sale | 5,451 | 70.83 | 386,077 |
| 2021-11-01 | Linetsky David (SVP, Life Sciences) | Option Ex | 5,451 | 4.71 | 25,674 |
| 2021-10-15 | Linetsky David (SVP, Life Sciences) | Sale | 5,452 | 65.36 | 356,331 |
| 2021-10-15 | Linetsky David (SVP, Life Sciences) | Option Ex | 5,452 | 4.71 | 25,678 |
| 2021-09-01 | Linetsky David (SVP, Life Sciences) | Sale | 4,978 | 70.56 | 351,267 |
| 2021-09-01 | Linetsky David (SVP, Life Sciences) | Option Ex | 4,978 | 4.71 | 23,446 |
| 2021-08-31 | Linetsky David (SVP, Life Sciences) | Sale | 474 | 71.84 | 34,052 |
| 2021-08-31 | Linetsky David (SVP, Life Sciences) | Option Ex | 474 | 4.71 | 2,232 |
| 2021-08-30 | Indig Chaim (Chief Executive Officer) | Sale | 54,672 | 71.71 | 3,920,310 |
| 2021-08-30 | Indig Chaim (Chief Executive Officer) | Option Ex | 54,672 | 6.37 | 348,260 |
| 2021-08-27 | Indig Chaim (Chief Executive Officer) | Sale | 57,556 | 71.92 | 4,139,542 |
| 2021-08-27 | Indig Chaim (Chief Executive Officer) | Option Ex | 57,556 | 4.71 | 271,088 |
| 2021-08-27 | Linetsky David (SVP, Life Sciences) | Sale | 21,455 | 71.89 | 1,542,442 |
| 2021-08-27 | Linetsky David (SVP, Life Sciences) | Option Ex | 21,455 | 2.55 | 54,710 |
| 2021-08-26 | Indig Chaim (Chief Executive Officer) | Sale | 800 | 70.05 | 56,036 |
| 2021-08-26 | Indig Chaim (Chief Executive Officer) | Option Ex | 800 | 4.71 | 3,768 |
| 2021-08-26 | Linetsky David (SVP, Life Sciences) | Sale | 800 | 70.07 | 56,054 |
| 2021-08-26 | Linetsky David (SVP, Life Sciences) | Option Ex | 800 | 2.55 | 2,039 |
| 2021-08-25 | Indig Chaim (Chief Executive Officer) | Sale | 600 | 70.03 | 42,018 |
| 2021-08-25 | Indig Chaim (Chief Executive Officer) | Option Ex | 600 | 4.71 | 2,826 |
| 2021-08-25 | Linetsky David (SVP, Life Sciences) | Sale | 500 | 70.04 | 35,019 |
| 2021-08-25 | Linetsky David (SVP, Life Sciences) | Option Ex | 500 | 2.55 | 1,275 |
| 2021-08-25 | Hoffman Allison C (General Counsel & Secretary) | Sale | 2,082 | 69.05 | 143,762 |
| 2021-08-06 | Indig Chaim (Chief Executive Officer) | Sale | 1,660 | 70.53 | 117,084 |
| 2021-08-06 | Indig Chaim (Chief Executive Officer) | Option Ex | 1,660 | 4.71 | 7,818 |
| 2021-08-05 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 5,273 | 69.72 | 367,638 |
| 2021-08-05 | Weintraub Michael | Sale | 8,236 | 70.12 | 577,549 |
| 2021-08-05 | Weintraub Michael | Option Ex | 8,236 | 2.03 | 16,719 |
| 2021-08-05 | Indig Chaim (Chief Executive Officer) | Sale | 28,120 | 70.27 | 1,976,020 |
| 2021-08-05 | Indig Chaim (Chief Executive Officer) | Option Ex | 28,120 | 4.71 | 132,445 |
| 2021-07-30 | Weintraub Michael | Sale | 10 | 70.00 | 700 |
| 2021-07-30 | Weintraub Michael | Option Ex | 10 | 2.03 | 20 |
Insider trading activities including stock purchases, stock sales, and option exercises
of PHR listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Phreesia, Inc. (symbol PHR,
CIK number 1412408) see
the Securities and Exchange Commission (SEC) website.